Estudios sobre la vacuna antipoliomielítica trivalente administrada por vía oral en una o dos dosis a niños de México
MetadataShow full item record
The antigenic capacity of one and of two doses of Lederle-Cox oral trivalent poliomyelitis vaccine was studied in a group of children aged from 6 months to 5 years living in Huitzilac (Morelos) and of Tlaxcala (Tlaxcala) in MexicoThe serologic conversion rate obtained with one dose in both villages was 32.3 per cent, 25.1 per cent, and 72.8 per cent for Types 1, 2, and 3, respectively. In a group of children in Tlaxcala the conversion percentage with two doses was 55.7 per cent for Type 1, 43.8 per cent for Type 2, and 89.3 per cent for Type 3. The Markham seronegativity index was 75.7 per cent before the vaccination and 28.6 per cent after the administration of the two doses. It should be noted that the second dose produced a higher conversion percentage than the first, especially in triple-negative childrenAlthough in general it is pointed out that the component of Type 2 of this vaccine is the least antigenic - as was confirmed by this study - that of Type 1 of the lot tested was also defective. The reasons for the low potency of the lot used are discussed. Mention is also made of the interference of the natural enteric viruses with the vaccine strains. The degree of dissemination of the latter to susceptible contacts was estimated to be around 8 per centDuring the study no cases of paralytic poliomyelitis or pathological manifestation attributable to the vaccine were observed(AU)
Studies on oral administration of one and of two oral doses of trivalent poliolmyelitis vaccine to children in Mexico
Showing items related by title, author, creator and subject.
Borgoño, José Manuel; Greiber, Rosa; Heras, Elsa; Carrillo, B; Solari, G; Concha, F (1971)Reactions to combined attenuvax-smallpox vaccine were studied, and were compared with those produced by each type of vaccine separately, in children from one to five years of age, controlled by maternal-child care centers ...
Efecto de la vacuna antineumocócica conjugada 10-valente en el área sur de Santiago de Chile, 2009-2015 Alvarado, Sylvina; Cavada, Gabriel; Villena, Rodolfo; Wilhelm, Jan; Budnik, Isolda; Lara, Cristian; Salinas, Ximena; Azpilcueta, Nury; Valenzuela, María Teresa (2018-12)[RESUMEN]. Objetivo. El objetivo de este estudio fue evaluar el efecto de la incorporación de la vacuna antineumococica 10-valente (PCV 10) en la incidencia de la enfermedad neumocócica invasora (ENI) y en la neumonía ...
Community acquired pneumonia incidence among children less than 5 years of age in Concordia, Argentina: vaccination impact Ruvinsky, Raúl O.; Rearte, Analía; Kupervaser, Judit; Gentile, Fernando; Haidar, Adriana; Cafure, Maria E.; Tito, Maria Elisa; Avaro, Federico; Cortiana, Cristina; Cozzani, Hugo; Véliz, Omar; Fossati, Sofia; Regueira, Mabel; Vizzotti, Carla (2018-11)[ABSTRACT]. Objective. To measure the effectiveness of pneumococcal conjugated vaccine (PCV13) against Community Acquired Pneumonia (CAP) and invasive pneumococcal disease, 2 years after the vaccine (2+1) was included into ...